Monte Rosa Therapeutics(GLUE)
$10.31-0.19 (-1.81%)
GLUE
Monte Rosa Therapeutics financials statements
$10.31
At close:-0.19 (-1.81%)
Want to see GLUE full AI Analyst Report?
Monte Rosa Therapeutics (GLUE) Income Statement
408 Followers
Monte Rosa Therapeutics Income Statement
Last quarter (Q3 2026), Monte Rosa Therapeutics's total revenue was $54.37M, an increase of 325.80% from the same quarter last year. In Q3, Monte Rosa Therapeutics's net income was $3.06M. See Monte Rosa Therapeutics’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 123.67M | $ 75.62M | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 115.32M | $ 67.50M | $ -6.22M | $ 0.00 | $ 0.00 | |
| $ 169.52M | $ 148.61M | $ 137.09M | $ 112.38M | $ 72.88M | |
| Depreciation and Amortization | $ 8.36M | $ 8.12M | $ 6.22M | $ 3.75M | $ 2.13M |
| $ -31.37M | $ -62.01M | $ -128.79M | $ -100.99M | $ -71.83M | |
| $ -54.21M | $ -81.11M | $ -143.31M | $ -112.38M | $ -72.88M | |
| $ 14.48M | $ 10.98M | $ 8.30M | $ 3.88M | $ -1.08M | |
| $ -39.72M | $ -70.13M | $ -135.01M | $ -108.50M | $ -73.96M | |
| $ -38.63M | $ -72.70M | $ -135.35M | $ -108.50M | $ -73.96M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.59 | $ -0.98 | $ -2.63 | $ -2.30 | $ -1.59 |
| Diluted EPS | $ -0.59 | $ -0.98 | $ -2.63 | $ -2.30 | $ -1.59 |
| Weighted Average Shares Outstanding | 65.54M | 73.91M | 51.40M | 47.23M | 46.54M |
| Weighted Average Shares Outstanding (Diluted) | 65.54M | 73.91M | 51.40M | 47.23M | 46.54M |
Currency in USD
